Timing of ibuprofen use and bone mineral density adaptations to exercise training

Journal of Bone and Mineral Research

Volumn 25, Issue 6, 2010, Pages 1415-1422

  Kohrt, Wendy M ^a   Barry, Daniel W ^b   Van Pelt, Rachael E ^a   Jankowski, Catherine M ^a   Wolfe, Pamela ^c   Schwartz, Robert S ^a  

^a Division of Geriatric Medicine   (United States)

^b Division of General Internal Medicine   (Germany)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Bone mineral density; Cyclooxygenase; Exercise training; Nonsteroidal anti inflammatory drugs; Prostaglandins

Indexed keywords

IBUPROFEN; PLACEBO;

ADAPTATION; ADULT; ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; HIP; HUMAN; LUMBAR SPINE; NORMAL HUMAN; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; WEIGHT BEARING;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY COMPOSITION; BONE DENSITY; CONTRACEPTIVE AGENTS; DRUG ADMINISTRATION SCHEDULE; EXERCISE; FEMALE; HUMANS; IBUPROFEN; PATIENT COMPLIANCE; TIME FACTORS; YOUNG ADULT;

EID: 77953486374     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.24     Document Type: Article

References (36)

1. Alam I, Warden SJ, Robling AG, Turner CH. Mechanotransduction in bone does not require a functional cyclooxygenase-2 (COX-2) gene. J Bone Miner Res. 2005;20:438-446.
2. Bakker AD, Klein-Nulend J, Burger EH. Mechanotransduction in bone cells proceeds via activation of COX-2, but not COX-1. Biochem Biophys Res Commun. 2003;305:677-683. (Pubitemid 36579284)
3. Bauer DC, Orwoll ES, Fox KM, et al. Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1996;11:29-35.
4. Carbone LD, Tylavsky FA, Cauley JA, et al. Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res. 2003;18:1795-1802.
5. Cheng MZ, Zaman G, Rawlinson SC, Pitsillides AA, Suswillo RF, Lanyon LE. Enhancement by sex hormones of the osteoregulatory effects of mechanical loading and prostaglandins in explants of rat ulnae. J Bone Miner Res. 1997;12:1424-1430. (Pubitemid 27375385)
6. Chow JW. Role of nitric oxide and prostaglandins in the bone formation response to mechanical loading. Exerc Sport Sci Rev. 2000;28:185-188.
7. Chow JW, Chambers TJ. Indomethacin has distinct early and late actions on bone formation induced by mechanical stimulation. Am J Physiol. 1994;267:E287-E292. (Pubitemid 24272445)
8. Chow JW, Fox SW, Lean JM, Chambers TJ. Role of nitric oxide and prostaglandins in mechanically induced bone formation. J Bone Miner Res. 1998;13:1039-1044. (Pubitemid 28265283)
9. Forwood MR. Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res. 1996;11:168-1693.
10. Gregory LS, Kelly WL, Reid RC, Fairlie DP, Forwood MR. Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats. Bone. 2006;39:134-142.
11. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. The FASEB Journal. 2008;22:383-390. (Pubitemid 351225574)
12. Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P. Bone mineral density and biomechanical properties of spine and femur of ovariectomized rats treated with naproxen. Bone. 1998;22:509-514. (Pubitemid 28226865)
13. Kasukawa Y, Miyakoshi N, Srivastava AK, et al. The selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivo. Tohoku J Exp Med. 2007;211:275-283. (Pubitemid 46488384)
14. Kimmel DB, Coble T, Lane N. Long-term effect of naproxen on cancellous bone in ovariectomized rats. Bone. 1992;13:167-172.
15. Kis B, Snipes JA, Busija DW. Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties. J Pharmocol Exp Therapeut. 2005;315:1-7. (Pubitemid 41380491)
16. Kohrt WM, Ehsani AA, Birge SJ Jr. Effects of exercise involving predominantly either joint-reaction or ground-reaction forces on bone mineral density in older women. J Bone Miner Res. 1997;12:1253-1261.
17. Kohrt WM, Ehsani AA, Birge SJ. HRT preserves increases in bone mineral density and reductions in body fat after a supervised exercise program. J Appl Physiol. 1998;84:1506-1512.
18. Lane N, Coble T, Kimmel DB. Effect of naproxen on cancellous bone in ovariectomized rats. J Bone Miner Res. 1990;5:1029-1035. (Pubitemid 20371548)
19. Lane NE, Bauer DC, Nevitt MC, Pressman AR, Cummings SR. Aspirin and nonsteroidal antiinflammatory drug use in elderly women: effects on a marker of bone resorption. The Study of Osteoporotic Fractures Research Group. J Rheumatol. 1997;24:1132-1136.
20. Li J, Burr DB, Turner CH. Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading. Calcif Tissue Int. 2002;70:320-329. (Pubitemid 36935448)
21. Li M, Thompson DD, Paralkar VM. Prostaglandin E(2) receptors in bone formation. Int Orthop. 2007;31:767-772.
22. Moldoveanu AI, Shephard RJ, Shek PN. The cytokine response to physical activity and training. Sports Med. 2001;31:115-144. (Pubitemid 32178874)
23. Morton DJ, Barrett-Connor E, Schneider DL. Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study. J Bone Miner Res. 1998;13:1924-1931. (Pubitemid 28535850)
24. Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007;65:S147-S151.
25. Nieman DC, Davis JM, Brown VA, et al. Influence of carbohydrate ingestion on immune changes after 2 h of intensive resistance training. J Appl Physiol. 2004;96:1292-1298. (Pubitemid 38392663)
26. Paulsen G, Benestad HB, Strom-Gundersen I, Morkrid L, Lappegard KT, Raastad T. Delayed leukocytosis and cytokine response to high-force eccentric exercise. Med Sci Sports Exerc. 2005;37:1877-1883.
27. Pead MJ, Lanyon LE. Indomethacin modulation of load-related stimulation of new bone formation in vivo. Calcif Tissue Int. 1989;45:34-40.
28. Raisz LG. Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. Am J Med. 2001;110 (Suppl 3A):43S-45S.
29. Richards JB, Joseph L, Schwartzman K, Kreiger N, Tenenhouse A, Goltzman D. The effect of cyclooxygenase-2 inhibitors on bone mineral density: results from the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2006;17:1410-1419.
30. Saino H, Matsuyama T, Takada J, Kaku T, Ishii S. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats. J Bone Miner Res. 1997;12:1844-1850.
31. Shen CL, Yeh JK, Wang X. Short-term supplementation of COX-2 inhibitor suppresses bone turnover in gonad-intact middle-aged male rats. J Bone Miner Metab. 2006;24:461-466.
32. Sibonga JD, Bell NH, Turner RT. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone. J Bone Miner Res. 1998;13:863-870.
33. Somjen D, Binderman I, Berger E, Harell A. Bone remodelling induced by physical stress is prostaglandin E2 mediated. Biochim Biophys Acta. 1980;627:91-100.
34. Thorsen K, Kristoffersson AO, Lerner UH, Lorentzon RP. In situ microdialysis in bone tissue. Stimulation of prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest. 1996;98:2446-2449.
35. van Staa TP, Leufkens HG, Cooper C. Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone. 2000;27:563-568.
36. Zaman G, Suswillo RF, Cheng MZ, Tavares IA, Lanyon LE. Early responses to dynamic strain change and prostaglandins in bone-derived cells in culture. J Bone Miner Res. 1997;12:769-777.